Universität Düsseldorf: Post et al., Int J Mol Sci. 2021

07/10/2021 | 12:46

Julia Post, Anja Schaffrath, Ian Gering, Sonja Hartwig, Stefan Lehr, N Jon Shah, Karl-Josef Langen, Dieter Willbold, Janine Kutzsche, Antje Willuweit.

Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1 G93A Transgenic Mice.

Int J Mol Sci. 2021 Jun 30;22(13):7066. doi: 10.3390/ijms22137066. PubMed ID: 34209129

Further Information:

PubMed

Dieter Willbold

Responsible for the content:

Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1 G93A Transgenic Mice. Post et al., Int J Mol Sci. 2021

Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1 G93A Transgenic Mice.
Post et al., Int J Mol Sci. 2021